Context Biopharma Inc.
Records under this name other than the patents Context Biopharma Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Showing 1 to 3 of 3 · Back to Context Biopharma Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,786,461 | Onapristone extended-release compositions and methods Lapsed on the fee record Ended Sep 29, 2024 · From the USPTO record | Lapsed on the fee record | Ended Sep 29, 2024 | From the USPTO record |
| US 10,548,905 | Amorphous onapristone compositions and methods of making the same Lapsed on the fee record Ended Feb 4, 2024 · From the USPTO record | Lapsed on the fee record | Ended Feb 4, 2024 | From the USPTO record |
| US 9,193,757 | Onapristone polymorphic forms and methods of use Lapsed on the fee record Ended Nov 24, 2023 · From the USPTO record | Lapsed on the fee record | Ended Nov 24, 2023 | From the USPTO record |